RAFAEL HOLDINGS, INC. Payments for (Proceeds from) Loans Receivable
RAFAEL HOLDINGS, INC. (RFL) reported Payments for (Proceeds from) Loans Receivable of $1.99 million for the 12-month period ending 2024-07-31, per its 10-K/A filed 2024-12-20.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForProceedsFromLoansReceivable · last filed 2024-12-20
- RAFAEL HOLDINGS, INC. payments for (proceeds from) loans receivable for the quarter ending 2024-07-31 was $0.00.
- RAFAEL HOLDINGS, INC. payments for (proceeds from) loans receivable for the quarter ending 2024-04-30 was $0.00.
- RAFAEL HOLDINGS, INC. payments for (proceeds from) loans receivable for the quarter ending 2024-01-31 was $1.74M.
- RAFAEL HOLDINGS, INC. payments for (proceeds from) loans receivable for the quarter ending 2023-10-31 was $250.00K.
- RAFAEL HOLDINGS, INC. payments for (proceeds from) loans receivable for fiscal 2024 was $1.99M, a 0.55% decline from fiscal 2023.
- RAFAEL HOLDINGS, INC. payments for (proceeds from) loans receivable for fiscal 2023 was $2.00M.
| Period end | Payments for (Proceeds from) Loans Receivable 3 month | Payments for (Proceeds from) Loans Receivable 6 month | Payments for (Proceeds from) Loans Receivable 9 month | Payments for (Proceeds from) Loans Receivable 12 month |
|---|---|---|---|---|
| 2024-07-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-20 | $0.00 derived: sum of 2 quarters · filed 2024-12-20 | $1.74M derived: sum of 3 quarters · filed 2024-12-20 | $1.99M 10-K/A · filed 2024-12-20 |
| 2024-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-06-14 | $1.74M derived: sum of 2 quarters · filed 2024-06-14 | $1.99M 10-Q · filed 2024-06-14 | $1.99M derived: sum of 4 quarters · filed 2024-12-11 |
| 2024-01-31 | $1.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-03-14 | $1.99M 10-Q · filed 2024-03-14 | $1.99M derived: sum of 3 quarters · filed 2024-12-11 | |
| 2023-10-31 | $250.00K 10-Q · filed 2024-12-11 | $250.00K derived: sum of 2 quarters · filed 2024-12-11 | ||
| 2023-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-30 | $2.00M 10-K · filed 2023-10-30 | ||
| 2023-04-30 | $2.00M 10-Q · filed 2023-06-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |